Cargando…
Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature
Thrombotic microangiopathy (TMA) is characterized by microangiopathic hemolytic anemia, thrombocytopenia and organ injury occurring due to endothelial cell damage and microthrombi formation in small vessels. TMA is primary when a genetic or acquired defect is identified, as in atypical hemolytic ure...
Autores principales: | Saleem, Maryam, Shaikh, Sana, Hu, Zheng, Pozzi, Nicola, Java, Anuja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204634/ https://www.ncbi.nlm.nih.gov/pubmed/35720299 http://dx.doi.org/10.3389/fimmu.2022.909503 |
Ejemplares similares
-
Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019) -
Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy
por: Okamura, Hiroshi, et al.
Publicado: (2021) -
Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020) -
Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
por: Trojnar, Eszter, et al.
Publicado: (2019) -
Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)